UFP Technologies IncUFPT
Price$296.82Intrinsic value$254.9614% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $254.96median of 6 methods · middle span $192-$361based on filings through 30 Jun 2026
Market Price $296.82Price as of 30 Sep 2026
Margin of Safety -14.1%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 10.2% (near-term consensus, capped) · years 2–5: 14.3%/yr (balance of the path).13.4% per year
Years 6–10: glide to demonstrated growth own history 24.1%, capped at 20%
Per-year rates
Yr 614.1%Yr 713.9%Yr 813.8%Yr 913.6%Yr 1013.4%
14.3% → 13.4%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1112.4%Yr 1211.3%Yr 1310.3%Yr 149.3%Yr 158.2%Yr 167.2%Yr 176.1%Yr 185.1%Yr 194.0%Yr 203.0%
13.4% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)24.1%
Discount rate (cost of equity) 9.6%
Volatility vs market (adjusted beta)1.04

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetUFP Technologies IncUFPTHealth Care
Valuation
P/E32.0×
P/S3.4×
P/B4.7×
EV / Revenue3.6×
EV / EBITDA—
Profitability
Gross margin28.8%
Operating margin15.2%
Net margin11.5%
FCF margin10.0%
Returns
ROE15.6%
ROA10.6%
ROIC12.7%
Growth
Revenue growth (YoY)25.2%
5-yr fwd EPS growth13.4%
Financial strength
Debt / Equity0.25×
Current ratio3.00×
Altman Z-Score8.6
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.